Advertisement
Platinum Priority – Editorial Referring to the article published on pp. 683–689 of this issue| Volume 67, ISSUE 4, P690-691, April 01, 2015

Retrospective Comparison of Cardiovascular Risk in Preselected Patients Undergoing Kidney Cancer Surgery: Reflection of Reality or Simply What We Want to Hear?

  • Jeffrey J. Tomaszewski
    Affiliations
    Division of Urology, Department of Surgery, MD Anderson Cancer Center at Cooper, Rowan University School of Medicine, Camden, NJ, USA
    Search for articles by this author
  • Alexander Kutikov
    Correspondence
    Corresponding author. Urologic Oncology, Fox Chase Cancer Center-Temple University Health System, 333 Cottman Avenue, Philadelphia, PA 19111, USA. Tel. +1 267 565 7722; Fax: +1 888 751 6615.
    Affiliations
    Division of Urologic Oncology, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA, USA
    Search for articles by this author
      In the current issue of European Urology, Capitanio et al [
      • Capitanio U.
      • Terrone C.
      • Antonelli A.
      • et al.
      Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a–T1b renal mass and normal preoperative renal function.
      ] present the results of a large multi-institutional collaborative effort to test the correlation between nephron-sparing surgery (NSS) and radical nephrectomy (RN) for the long-term risk of postsurgical cardiovascular events (CVEs) after accounting for baseline cardiovascular risk factors.
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to European Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Capitanio U.
        • Terrone C.
        • Antonelli A.
        • et al.
        Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a–T1b renal mass and normal preoperative renal function.
        Eur Urol. 2015; 67: 683-689
        • Grimes D.A.
        • Schulz K.F.
        Bias and causal associations in observational research.
        Lancet. 2002; 359: 248-252
        • Smaldone M.C.
        • Egleston B.
        • Uzzo R.G.
        • Kutikov A.
        Does partial nephrectomy result in a durable overall survival benefit in the Medicare population?.
        J Urol. 2012; 188: 2089-2094
        • Smaldone M.C.
        • Churukanti G.
        • Simhan J.
        • et al.
        Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment.
        Urology. 2013; 81: 269-275
        • Shuch B.
        • Hanley J.
        • Lai J.
        • et al.
        Overall survival advantage with partial nephrectomy: a bias of observational data?.
        Cancer. 2013; 119: 2981-2989
        • Kutikov A.
        • Smaldone M.C.
        • Uzzo R.G.
        Partial versus radical nephrectomy: balancing nephrons and perioperative risk.
        Eur Urol. 2013; 64: 607-609
        • Korn E.L.
        • Freidlin B.
        Methodology for comparative effectiveness research: potential and limitations.
        J Clin Oncol. 2012; 30: 4185-4187
        • Van Poppel H.
        • Da Pozzo L.
        • Albrecht W.
        • et al.
        A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
        Eur Urol. 2011; 59: 543-552
      1. Tomaszewski JJ, Smaldone MC, Uzzo RG, Kutikov A. Is radical nephrectomy a legitimate therapeutic option in patients with renal masses amenable to nephron-sparing surgery? BJU Int. In press. http://dx.doi.org/10.1111/bju.12696

        • Weight C.J.
        • Miller D.C.
        • Campbell S.C.
        • Derweesh I.H.
        • Lane B.R.
        • Messing E.M.
        The management of a clinical T1b renal tumor in the presence of a normal contralateral kidney.
        J Urol. 2013; 189: 1198-1202

      Linked Article